Evidence map›Paper›PMID 39418655›Full record

ArticleACS applied materials & interfaces2025

Construction of Methotrexate-Loaded Bi

Pranjyan Dash, Nandini Nataraj, Pradeep Kumar Panda, Ching-Li Tseng, Yu-Chien Lin, Rajalakshmi Sakthivel, Ren-Jei Chung

Abstract read
In one paragraph

Article in ACS applied materials & interfaces, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Pranjyan DashDepartment of Chemical Engineering and Biotechnology, National Taipei University of Technology (Taipei Tech), Taipei 10608, Taiwan.ORCID 0000-0001-7143-3194
Nandini NatarajDepartment of Chemical Engineering and Biotechnology, National Taipei University of Technology (Taipei Tech), Taipei 10608, Taiwan.
Pradeep Kumar PandaDepartment of Chemical Engineering and Materials Science, Yuan Ze University, Taoyuan City 32003, Taiwan.ORCID 0000-0002-0443-4426
Ching-Li TsengGraduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei City 110, Taiwan.ORCID 0000-0001-9446-4030
Yu-Chien LinDepartment of Chemical Engineering and Biotechnology, National Taipei University of Technology (Taipei Tech), Taipei 10608, Taiwan.ORCID 0000-0003-3290-439X
Rajalakshmi SakthivelDepartment of Chemical Engineering and Biotechnology, National Taipei University of Technology (Taipei Tech), Taipei 10608, Taiwan.
Ren-Jei ChungDepartment of Chemical Engineering and Biotechnology, National Taipei University of Technology (Taipei Tech), Taipei 10608, Taiwan.ORCID 0000-0002-0655-3680

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A combination of therapeutic modalities in a single nanostructure is crucial for a successful cancer treatment. Synergistic photothermal therapy (PTT) can enhance the effects of chemodynamic therapy (CDT) and chemotherapy, which could intensify the therapeutic efficacy to induce cancer cell apoptosis. In this study, Fe and Mn on a zeolitic imidazolate framework (ZIF-8) (Fe/Mn-ZIF-8; FMZ) were synthesized through ion deposition. Furthermore, bismuth sulfide nanorods (Bi

Indexed as

BismuthIronMethotrexateNanocompositesSulfidesZeolitesAnimalsAntineoplastic AgentsCell Line, TumorHumansImidazolesManganeseMetal-Organic FrameworksMiceMice, Inbred BALB CNeoplasmsAntineoplastic AgentsBismuthbismuth sulfideImidazolesIronManganeseMetal-Organic FrameworksMethotrexateSulfidesZeolitesZIF-8 metal-organic frameworkBi2S3 nanorodschemodynamic therapychemotherapymetal-doped ZIF-8metal−organic frameworksphotothermal therapy

Identifiers

PMID39418655
PMCPMC11783362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.